New Ray Medicine International Holding Limited

新銳醫藥國際控股有限公司

(Incorporated in Bermuda with limited liability)

(Stock Code: 6108)

FORM OF PROXY

Form of proxy for use by shareholders of New Ray Medicine International Holding Limited (the "Company") at the annual general meeting (the "Meeting") of the Company to be held at 1/F., Town Health Technology Centre, 10-12 Yuen Shun Circuit, Siu Lek Yuen, Shatin, Hong Kong on Tuesday, 20 June 2017 at 9:00 a.m. and any adjournment thereof.

I/We(note a) of being the registered holder(s) of (noteb) shares of HK$0.05 each in the share capital of the Company hereby appoint (notec) the Chairman of the Meeting, or of to act as my/our proxy (notec) at the Meeting and at any adjournment thereof and to vote on my/our behalf as directed below.

My/Our vote(s) to be cast on a poll is/are as follows: (Please tick ("") the appropriate boxes (noted) )

ORDINARY RESOLUTIONS#

FOR (note d)

AGAINST (note d)

1.

To receive and approve the audited consolidated financial statements and the reports of the directors and the auditors of Company for the year ended 31 December 2016

2.

(a) To re-elect Mr. Ho Hau Cheung, BBS, MH as an independent non-executive director

(b) To re-elect Mr. Leung Chi Kin as an independent non-executive director

(c) To authorise the board of directors to fix the directors' remuneration

3.

To re-appoint Deloitte Touche Tohmatsu as the Company's auditors and authorise the board of directors to fix its remuneration

4.

To grant a general mandate to the directors to issue, allot or otherwise deal with the Company's shares

5.

To grant a general mandate to the directors to repurchase the Company's shares

6.

To extend the general mandate granted to the directors to allot, issue or deal with the Company's shares by the number of shares repurchased

7.

To approve the refreshment of the 10% general limit of the share option scheme of the Company

# Full text of the resolutions is set out in the notice of the Meeting dated 18 May 2017.

Dated this day of , 2017

Shareholder's signature: (notes e, f, g, h andi)

Notes:

  1. Full name(s) and address(es) are to be inserted in BLOCK CAPITALS.

  2. Please insert the number of shares registered in your name(s). If no number is inserted, this form of proxy will be deemed to relate to all the shares in the capital of the Company registered in your name(s).

  3. A proxy needs not be a member of the Company but must attend the Meeting in person to represent you. If you wish to appoint some person other than the Chairman of the Meeting as your proxy, please delete the words "the Chairman of the Meeting, or" and insert the name and address of the person appointed proxy in the space provided. If no name is inserted, the Chairman of the Meeting will act as your proxy.

  4. If you wish to vote for the resolutions set out above, please tick ("") the box marked "For". If you wish to vote against the resolutions set out above, please tick ("") the box marked

    "Against". If this form returned is duly signed but without specific direction on the proposed resolution, the proxy will vote or abstain at his discretion in respect of that resolution. A proxy will also be entitled to vote at his discretion on any resolution properly put to the Meeting other than that set out in the notice convening the Meeting.

  5. In the case of a joint holding, this form of proxy may be signed by any joint holder, but if more than one joint holder is present at the Meeting, whether in person or by proxy, that one of the joint holders whose name stands first on the register of members in respect of the relevant joint holding shall alone be entitled to vote in respect thereof.

  6. This form of proxy must be signed by a shareholder, or his attorney duly authorised in writing, or if the shareholder is a corporation, either under its seal or under the hand of an officer, attorney or other person duly authorised.

  7. To be valid, this form of proxy together with any power of attorney or other authority (if any) under which it is signed or a certified copy of such power or authority must be deposited at the offices of the Company's branch share registrar and transfer office in Hong Kong, Tricor Investor Services Limited at Level 22, Hopewell Centre, 183 Queen's Road East, Hong Kong as soon as possible and in any event by 9:00 a.m. (Hong Kong time) on Sunday, 18 June 2017 or not less than 48 hours before the time appointed for holding any adjourned Meeting.

  8. Any alteration made to this form of proxy should be initialled by the person who signs the form.

  9. Completion and return of this form will not preclude you from attending and voting in person at the Meeting or any adjournment thereof if you so wish. In that event, this form of proxy will be deemed to be revoked.

  10. References to time and dates in this form of proxy are to Hong Kong time and dates.

PERSONAL INFORMATION COLLECTION STATEMENT

"Personal Data" in this statement has the same meaning as "personal data" defined in the Personal Data (Privacy) Ordinance, Chapter 486 of the Laws of Hong Kong ("PDPO"), which include your and your proxy's name and address. Your supply of the Personal Data is on a voluntary basis and for the purpose of processing your instructions as stated in this form of proxy (the "Purposes"). If you fail to supply sufficient information, the Company may not be able to process your instructions. The Company may disclose or transfer the Personal Data to its subsidiaries, the Share Registrar and/or third party service provider who provides administrative, computer and other services to the Company for use in connection with the Purposes and to such parties who are authorised by law to request the information or are otherwise relevant for the Purposes and need to receive the information. The Personal Data will be retained for such period as may be necessary to fulfil the Purposes (including for verification and record purposes). Request for access to and/or correction of the Personal Data can be made in accordance with the provisions of the PDPO and any such request should be in writing and sent to the Privacy Compliance Officer of Tricor Investor Services Limited at the above address.

New Ray Medicine International Holding Ltd. published this content on 17 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 08 June 2017 09:55:21 UTC.

Original documenthttp://www.newraymedicine.com/PublicSite/files/New Ray Medicine_E_GM Cir proxy.pdf

Public permalinkhttp://www.publicnow.com/view/BCFEE67CD70ABCD33594CC8F1F7EDF0B8F76A2B9